Liver Disease
📧 Sign up to get email alerts when something new happens for Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Effectiveness of ActiSight™ Needle Guidance System in Patients Undergoing CT-Guided Procedures [Phase 4]
Phase 4 trial evaluating the ActiSight Needle Guidance System for CT-guided procedures in patients with lung and liver diseases has complete…
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Comparison of the Hemostatic Patch to Fibrin Sealant (TachoSil®) in Subjects Undergoing Hepatic Surgery [NA]
A completed clinical trial comparing a hemostatic patch to fibrin sealant (TachoSil) in patients undergoing liver surgery; results were post…
-
CLINICAL_TRIALS trial_result · 2012-07-06Clinical Trial Update: Relative-dose-response Test (RDR) Adaptation for Chronic Liver Disease [NA]
The clinical trial evaluating a relative-dose-response (RDR) test adaptation for chronic liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-14Clinical Trial Update: Study Evaluating The PK And Safety Of Neratinib In Healthy Subjects And Subjects With Chronic Liver Disease [Phase 1]
This Phase 1 trial evaluates the pharmacokinetics and safety of neratinib in healthy subjects and in individuals with chronic liver disease …
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: TachoSil Paediatric Liver Trial (TC-019-IN) [Phase 3]
Phase 3 pediatric liver trial of TachoSil (TC-019-IN) sponsored by Nycomed has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-04-24Clinical Trial Update: A Study to Evaluate the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Hepatic Function and Subjects With Moderate Hepatic Impairment [Phase 1]
Phase 1 pharmacokinetic study comparing hydrocodone extended-release CEP-33237 in subjects with normal hepatic function and those with moder…
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients [Phase 2]
A National Institute of Allergy and Infectious Diseases–sponsored Phase 2 trial evaluated immune suppression using alemtuzumab and tacrolimu…
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis [Phase 3]
Phase 3 clinical trial update for a breath test (BreathID 13C-Methacetin Breath Test) aimed at detecting cirrhosis in chronic liver disease;…
-
CLINICAL_TRIALS trial_result · 2012-02-02Clinical Trial Update: Evaluation of Liver Fibrosis Staging With Acoustic Radiation Force Impulse Elastography
This clinical trial update reports on evaluating liver fibrosis staging with Acoustic Radiation Force Impulse elastography in chronic liver …
-
CLINICAL_TRIALS trial_result · 2011-08-18Clinical Trial Update: A Phase II Study of DMP 115 to Assess Focal Liver Lesions [Phase 2]
Phase II study of DMP 115 for focal liver lesions has completed. Sponsor: Lantheus Medical Imaging.
-
CLINICAL_TRIALS trial_result · 2011-07-13Clinical Trial Update: Study to Evaluate Efficacy, Safety and Tolerability of PENNEL Capsule in the Patients With Chronic Liver Disease [Phase 2]
Phase 2 study evaluating PENNEL Capsule for chronic liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-07-13Clinical Trial Update: Study to Evaluate Efficacy and Safety of PENNEL Capsule in the Patients With Chronic Liver Disease [Phase 3]
Phase 3 trial evaluating PENNEL Capsule for chronic liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects [Phase 1]
Phase 1 study assessing pharmacokinetics and safety of Naproxcinod in hepatic impairment patients versus healthy subjects; the trial is comp…
-
CLINICAL_TRIALS trial_result · 2011-05-20Clinical Trial Update: MMF After Pediatric Liver Transplantation [NA]
Clinical trial evaluating mycophenolate mofetil after pediatric liver transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2011-04-27Clinical Trial Update: Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV) [Phase 2]
Phase 2 trial evaluating pegylated interferon alfa-2a as maintenance therapy and its effect on liver disease progression in people co-infect…
-
CLINICAL_TRIALS trial_result · 2011-04-18Clinical Trial Update: Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver Diseases [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of adding ursodeoxycholic acid to a DPP-4 inhibitor in adults with type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: A Study of Dasatinib to See How Liver Impaired and Healthy Subjects Process and React to the Study Drug
Completed pharmacokinetic study evaluating how liver impairment affects dasatinib processing in liver-impaired and healthy subjects. The tri…
-
CLINICAL_TRIALS trial_result · 2011-03-03Clinical Trial Update: Peripheral Immunologic Response of Solid Organ Transplant Recipients to Depletion Versus Non-depletion Protocols
A completed clinical trial comparing depletion versus non-depletion immunosuppressive protocols in solid organ transplant recipients, examin…
-
CLINICAL_TRIALS trial_result · 2010-12-08Clinical Trial Update: Allogene MSCs Transplantation in Liver for Patients With Chronic Liver Diseases Through Portal Vein by Ultrasound Guiding
A clinical trial evaluating allogeneic mesenchymal stem cell transplantation into the liver via the portal vein with ultrasound guidance for…
-
CLINICAL_TRIALS trial_result · 2010-11-08Clinical Trial Update: Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures [Phase 3]
Phase 3 trial investigating eltrombopag to reduce platelet transfusions in patients with chronic liver disease and thrombocytopenia undergoi…
-
CLINICAL_TRIALS trial_result · 2010-10-07Clinical Trial Update: A Study to Assess the Effect of Hepatic Function on the Pharmacokinetics and Safety of ASP1941 [Phase 1]
Phase 1 study evaluating how hepatic function influences the pharmacokinetics and safety of ASP1941; the trial is completed.
-
CLINICAL_TRIALS trial_result · 2010-10-07Clinical Trial Update: Study of Resistance Strengthening Versus Ambulation Post-Liver Transplant [NA]
A completed University of Miami study compared resistance strengthening to standard ambulation to evaluate rehabilitation outcomes after liv…
-
CLINICAL_TRIALS trial_result · 2010-09-23Clinical Trial Update: Phase 2, Pharmacokinetics Study of Eltrombopag in Japanese Thrombocytopenic Subjects With Chronic Liver Disease [Phase 2]
Phase 2 pharmacokinetics study of eltrombopag in Japanese patients with thrombocytopenia due to chronic liver disease; the study has complet…
-
CLINICAL_TRIALS trial_result · 2010-09-06Clinical Trial Update: Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice. [Phase 4]
Phase 4 clinical trial evaluating different schedules of pegylated interferon and ribavirin for chronic hepatitis C in real-world practice. …
-
CLINICAL_TRIALS trial_result · 2010-04-14Clinical Trial Update: The Effect of Purple Sweet Potato (PSP)-Juice on Liver Enzymes and Blood Pressure [NA]
A completed clinical trial evaluated the effects of Purple Sweet Potato Juice on liver enzymes and blood pressure. The trial was sponsored b…